In particular, Rosengren et al. (1999) demonstrated higher CSF NFL levels in patients with FTD, AD, and vascular dementia (VaD) in comparison with healthy individuals and hypothesized that raised NFL levels were the consequence of degeneration of the brain white matter in those diseases (Table 3). This evidence concerns the gene NEFL and Alzheimer disease.